Hiranthi Jayasuriya
Research Subjects
Hiranthi Jayasuriya has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Deborah L. Zink
Merck Research Laboratories, P. O. Box 2000, Rahway, New Jersey 07065, USA, Fax: (1) 732‐5946880
4 shared publications- Olga Genilloud
Fundación Medina, Granada, Spain, Spain
3 shared publications Sheo B. Singh
Merck Research Laboratories, P. O. Box 2000, Rahway, New Jersey 07065
3 shared publicationsAngela Basilio
Centro de Investigación Básica, Merck Sharp & Dohme de España, S. A. Josefa Valcárcel 38, Madrid 28027, Spain
2 shared publicationsChaowei Zhang
Merck Research Laboratories, P. O. Box 2000, Rahway, New Jersey 07065, USA, Fax: (1) 732‐5946880
2 shared publicationsFrancisca Vicente
Centro de Investigación Básica, Merck Sharp & Dohme de España, S. A. Josefa Valcárcel 38, Madrid 28027, Spain
2 shared publications
Latest Publications
- 17 July 2007
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 70 (8) , 1364-1367
Isolation, Structure, and Coccidiostat Activity of Coccidiostatin A
Coccidiosis is one of the more common and costly diseases in poultry that is caused by various Eimeria species. In our quest to discover coccidiostats from natural products, we discovered a microbial fermentation extract that exhibited in vivo anticoccidial activity. Fractionation of this extract led to the discovery of two potent antiprotozoals, emecorrugatin A (1) and coccidiostatin A (2). The former compound exhibited only in vitro activity, whereas the latter new compound exhibited in vivo activity against Eimeria species in chickens at 150 ppm dosed in chicken feed. The isolation, structure elucidation, relative configuration, and activity of coccidiostatin A (2) are described.
- 17 July 2007
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 70 (8) , 1364-1367
Isolation, Structure, and Coccidiostat Activity of Coccidiostatin A
Coccidiosis is one of the more common and costly diseases in poultry that is caused by various Eimeria species. In our quest to discover coccidiostats from natural products, we discovered a microbial fermentation extract that exhibited in vivo anticoccidial activity. Fractionation of this extract led to the discovery of two potent antiprotozoals, emecorrugatin A (1) and coccidiostatin A (2). The former compound exhibited only in vitro activity, whereas the latter new compound exhibited in vivo activity against Eimeria species in chickens at 150 ppm dosed in chicken feed. The isolation, structure elucidation, relative configuration, and activity of coccidiostatin A (2) are described.
- 11 June 2007
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 46 (25) , 4684-4688
Isolation and Structure of Platencin: A FabH and FabF Dual Inhibitor with Potent Broad‐Spectrum Antibiotic Activity
- 11 June 2007
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 46 (25) , 4684-4688
Isolation and Structure of Platencin: A FabH and FabF Dual Inhibitor with Potent Broad‐Spectrum Antibiotic Activity
- 11 June 2007
- Published by Wiley in Angewandte Chemie
- Vol. 119 (25) , 4768-4772
Isolation and Structure of Platencin: A FabH and FabF Dual Inhibitor with Potent Broad‐Spectrum Antibiotic Activity
- 11 June 2007
- Published by Wiley in Angewandte Chemie
- Vol. 119 (25) , 4768-4772
Isolation and Structure of Platencin: A FabH and FabF Dual Inhibitor with Potent Broad‐Spectrum Antibiotic Activity
- 1 February 2004
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 67 (2) , 228-231
Rediocides B−E, Potent Insecticides from Trigonostemon reidioides
Four new congeners, rediocides B−E (2−5), of the previously reported rediocide A (1) were isolated from a methanol extract of the roots of the plant Trigonostemon reidioides. The structures of these minor analogues were elucidated by comparison of their NMR and mass spectral data with those of rediocide A and confirmed by extensive 2D NMR spectral analysis. They all possess potent activity against fleas (Ctenocephalides felis) in an artificial membrane feeding system and exhibited LD90 values ranging from 0.25 to 0.5 ppm.
- 1 February 2004
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 67 (2) , 228-231
Rediocides B−E, Potent Insecticides from Trigonostemon reidioides
Four new congeners, rediocides B−E (2−5), of the previously reported rediocide A (1) were isolated from a methanol extract of the roots of the plant Trigonostemon reidioides. The structures of these minor analogues were elucidated by comparison of their NMR and mass spectral data with those of rediocide A and confirmed by extensive 2D NMR spectral analysis. They all possess potent activity against fleas (Ctenocephalides felis) in an artificial membrane feeding system and exhibited LD90 values ranging from 0.25 to 0.5 ppm.
- 4 July 2002
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 65 (8) , 1091-1095
Durhamycin A, a Potent Inhibitor of HIV Tat Transactivation
Tat is a small HIV protein essential for both viral replication and the progression of HIV disease. In our efforts to discover Tat inhibitors from natural product screening of microbial fermentation extracts, we discovered durhamycin A (1) as a potent inhibitor (IC50 = 4.8 nM) of Tat transactivation. Detailed NMR and MS/MS studies were utilized to elucidate the structure of 1 as a new member of the aureolic acid family of antibiotics. It consists of tetrasaccharide and disaccharide moieties attached to the aglycone, which is hitherto unknown in the aureolic acid family. Three other novel analogues, durhamycin B (2), compound (3), and the aglycone (4), were also discovered or chemically prepared that were less potent than durhamycin A.
- 4 July 2002
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 65 (8) , 1091-1095
Durhamycin A, a Potent Inhibitor of HIV Tat Transactivation
Tat is a small HIV protein essential for both viral replication and the progression of HIV disease. In our efforts to discover Tat inhibitors from natural product screening of microbial fermentation extracts, we discovered durhamycin A (1) as a potent inhibitor (IC50 = 4.8 nM) of Tat transactivation. Detailed NMR and MS/MS studies were utilized to elucidate the structure of 1 as a new member of the aureolic acid family of antibiotics. It consists of tetrasaccharide and disaccharide moieties attached to the aglycone, which is hitherto unknown in the aureolic acid family. Three other novel analogues, durhamycin B (2), compound (3), and the aglycone (4), were also discovered or chemically prepared that were less potent than durhamycin A.